Tylah Tully looks at Vertex Minerals and its growing high-grade gold production in the latest episode of Stockhead's Who’s ...

The stock of niche financial software company Vertex ( VERX 4.13%) didn't get a very good start to the trading week at all.

Vertex, Inc. (NASDAQ: VERX) (“Vertex” or the “Company”), a leading global provider of indirect tax solutions, today announced financial results for its third quarter ended September 30, 2025 and the ...

If you're holding shares of Vertex Pharmaceuticals or thinking about adding some to your portfolio, you're not alone in wondering what the right move is. The stock's recent momentum may have caught ...

If your Word equation is not converting to professional format, you’re not alone. Some users have reported that equations typed in Microsoft Word on a Windows 11/10 PC fail to switch from linear text ...

Kapiva is currently operating at an annual revenue run rate (ARR) of Rs 550 crore, up from Rs 350 crore in FY25, reflecting strong consumer adoption across categories and channels Bengaluru-based ...

Kapiva, a healthcare brand focused on Ayurveda-based products, has raised $60 million in a Series D funding round. The round included $28 million in primary capital and was led by 360 ONE Asset and ...

Collectors of Lego's wide-ranging race car models and Formula 1 fans have another chance to buy the Amazon-exclusive 10-in-1 bundle that quickly sold out at launch earlier this year. The Lego Speed ...

Vertex Pharmaceuticals recently announced that the FDA has granted Breakthrough Therapy Designation to povetacicept for IgA nephropathy, along with key clinical advancements in its kidney disease ...

- Food and Drug Administration granted Breakthrough Therapy Designation for povetacicept in IgA nephropathy; on track to file for accelerated approval in the U.S. in H1 2026 if 36-week interim ...